Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Tranexamic Acid(TNA) in Preventing Blood Loss During and After Total Hip Arthroplasty

NCT02587845 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT02587845
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02587845 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Tranexamic Acid(TNA) in Preventing Blood Loss During and After Total Hip Arthroplasty
Lead sponsor
Samsung Medical Center
Phase
Phase 3
Overall status
Unknown status
Start date
October 31, 2015
Completion date
December 31, 2016
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding, transfusion related complication